Akhil Raghuram, MD
Sleep Medicine · Vancouver, WANPI 1851462725
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Jazz Pharmaceuticals Inc. accounts for 68.8% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $4,079 and has fallen 60.4% since, to $1,615 in 2025. Among sleep medicine clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 87 payments — averaging $84.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$5K
- Inspire Medical Systems, Inc.$947
- Harmony Biosciences LLC$362
- Avadel CNS Pharmaceuticals, LLC$302
- Axsome Therapeutics, Inc.$285
- ZOLL Respicardia, Inc.$178
- plus $203 from 4 others
What the payments were for
- Consulting fees$3,36246%
- Travel & lodging$6909%
- Food & beverage$3,03141%
- Education$2243%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 36 | $5,031 |
| Inspire Medical Systems, Inc. | 11 | $947 |
| Harmony Biosciences LLC | 11 | $362 |
| Avadel CNS Pharmaceuticals, LLC | 9 | $302 |
| Axsome Therapeutics, Inc. | 13 | $285 |
| ZOLL Respicardia, Inc. | 1 | $178 |
| Idorsia Pharmaceuticals US Inc | 2 | $112 |
| Vanda Pharmaceuticals Inc. | 2 | $39 |
| Lilly USA, LLC | 1 | $30 |
| Azurity Pharmaceuticals, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,308 in reported general payments places this provider in the 90th percentile of 67 sleep medicine providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XywavSodium,calcium,mag,pot Oxybate | 17 | $337,679 |
| Zolpidem Tartrate | 125 | $158 |
| Gabapentin | 14 | $72 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Vancouver
- Beenish KhwajaVancouver$175
- Muhammad UsamaAuburn$73K
- Vrushali GersappeEverett$56K
- Gandis MazeikaEdmonds$30K
- Meredith BroderickBellevue$8K
- Zeyad MorcosKirkland$6K
- Flavia ConsensSeattle$5K
- Ken HeSeattle$5K
- Teresa JacobsBellevue$5K
- Reuben WaliaBellevue$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.